Table 5.
Multivariate Cox proportional hazards analysis for posttransplant hepatitis B virus recurrence
| Factor | Hazard ratio | 95%CI | P value | |
| Pre-LT with HCC | Yes vs No | 1.718 | 1.243-2.375 | 0.001 |
| Pre-LT serum HBV DNA ≥ 105 copies/mL | Yes vs No | 1.370 | 0.989-1.897 | 0.048 |
| Pre-LT using ETV | Yes vs No | 0.166 | 0.019-1.484 | 0.108 |
| Post-LT HBV prophylactic protocol | HBIG + LAM vs HBIG + ETV | 2.127 | 0.416-3.055 | 0.046 |
| Donor profiles | ||||
| Donor gender | Male vs Female | 0.632 | 0.156-1.144 | 0.201 |
| Donor HBsAb positivity | Positive vs Negative | 0.526 | 0.265-1.045 | 0.066 |
LT: Liver transplantation; HCC: Hepatocellular carcinoma; HBV DNA: Hepatitis B virus deoxyribonucleic acid; ETV: Entecavir; HBIG: Hepatitis B immunoglobulin; LAM: Lamivudine; HBsAb: Hepatitis B surface antibody.